Navigation Links
Dartmouth researchers zero-in on a gene that heightens muscle performance

A group of researchers, led by scientists at Dartmouth Medical School and Dartmouth College, have discovered and examined a gene that is capable of changing muscle metabolism and performance. // The researchers are optimistic that this discovery could assist in the management of muscle diseases.

The researchers have found that the enzyme called AMP-activated protein kinase (or AMPK) is responsible for realizing the best muscle activity.

The team bred a mouse that genetically expressed AMPK in an activated state. Like a trained athlete, this mouse enjoyed increased capacity to exercise, manifested by its ability to run three times longer than a normal mouse before exhaustion. One particularly striking feature of the finding was the accumulation of muscle glycogen, the stored form of carbohydrates, a condition that many athletes seek by "carbo-loading" before an event or game. The study appears in the Nov. 14 online issue of the American Journal of Physiology: Endocrinology and Metabolism.

"Our genetically altered mouse appears to have already been an exercise program," says Lee Witters, the Eugene W. Leonard 1921 Professor of Medicine and Biochemistry at Dartmouth Medical School and professor of biological sciences at Dartmouth College. "In other words, without a prior exercise regimen, the mouse developed many of the muscle features that would only be observed after a period of exercise training."

Witters, whose lab led the study, explains that this finding has implication for anyone with a muscle disease and especially for the growing proportion of the population that is aging. Deteriorating muscles often make the elderly much more prone to fall, leading to hip and other fractures. According to Witters, there is tremendous interest in the geriatric field to find ways to improve muscle performance.

"We now wonder if it's possible to achieve elements of muscular fitness without having to exercise, which
'"/>




Page: 1 2

Related medicine news :

1. Vitamin Extends Life in Yeast, Dartmouth Medical School Researchers Find
2. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
3. Gene researchers make Malaria-resistant mosquito
4. Calcium Supplementation May Not Actually Prevent colon cancer say researchers
5. Lung cancer molecular profile discovered by researchers.
6. A great hope for quitters of smoking by researchers
7. Vitamins may not protect against cancer say researchers
8. Autoimmune disorders studied in detail by U-M researchers.
9. A high BMI may not determine obesity, researchers say
10. Medical researchers being stifled by NHS Red tape
11. Tissue implant scandal heightens FDA’s concer
Post Your Comments:
(Date:12/2/2008)...Calif., Dec. 2 ,Attainia and The N...d they,will deploy Attainia,s suite of web-based ...rusts within the United Kingdom. , "NHSSC h...olutions for the,Hospital trusts in the United Ki... "We recognize that NHSSC is building one of the ...
(Date:12/2/2008)...wire/ -- TYRX, Inc., a leader in the development a...ducts, today announced the appointment of David El...for commercial operations. , , Mr. Elliot b...evice industry. Mr. Elliot joins TYRX from Valam C...g laser-based antimicrobial and vascular plaque de...
(Date:12/2/2008)...re/ -- BioIQ , the leader in consumer-friendly he..., who provides services that include wellness, hea...care management as well as case management of acut...loyers, and government agencies, will work togethe...rting tools as part of Alere,s Personal Health Sol...
(Date:12/2/2008)... form an integral part of most of,original equipm...ore become,essential for service providers in the...in competitive and constantly improve their servic...: http://www.newscom.com/cgi-bin/prnh/20081117/F...livan ( http://www.medicalimaging.frost.com ),Eur...
Breaking Medicine News(10 mins):Health News:The National Health Service and Attainia Move to Modernize Medical Capital Equipment Budgeting and Planning for the United Kingdom 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3
Washington’s governor has made a move that would please even his political// opponents. The bill is expected to extend health insurance to 38, 000 children in Washington. According to the go
... tea may help fight lung cancer, the leading cause... the world, shows a recent study//. Qing-Yi Lu, Ph...sity of California at Los Angeles (UCLA) and other...n lung cancer cells to a decaffeinated green tea e...
...in-Computer Interface (BCI) provides a new communi...puter//. Mental activity leads to changes of elect...ram (EEG) or Electrocorticogram (ECoG). The BCI sy...a control signal which can, for example, be used a...
...ent study indicates the negative impact of soft dr...niversity in Connecticut says that consumption// o...ty, diabetes and a host of other illnesses. Brown... 88 studies on this topic support a ban on the con...
Other Medicine News:Health News:More US Children to Be Covered by Health Insurance 2
(Date:12/1/2008)...wire-USNewswire/ -- New research has found that th...tomography (CT) scanner in an emergency room can s... who receive a potentially life-saving treatment. ...ical Center (NSMC)-Salem Hospital in Salem, Mass.,...the Radiological Society of North America (RSNA). ...
(Date:12/1/2008)... Vanda Pharmaceuticals In...ancet , one of the world,s leading medical journal...an regulator, experimental compound tasimelteon (V...s entitled "Melatonin agonist tasimelteon (VEC-162...wo randomised controlled multicentre trials." Resu...
(Date:12/1/2008)...wswire/ -- S*BIO Pte Ltd today announced the initi...otent and orally-active JAK2 inhibitor, in leading...ronic idiopathic myelofibrosis (CIMF). , , ...tolerability of SB1518 in patients with CIMF and i...1 part of the study will assess the safety profile...
(Date:12/1/2008)...phatasia Treated With ENB-0040 at Children,s Hospi... MONTREAL, Dec. 1 Enobia Pharma, a...eloping novel therapeutics for serious bone disord... in its clinical program for hypophosphatasia was ...Therapy (ERT) with ENB-0040 for the treatment of t...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sea cucumbers fast track organ regrowth by healing their wounds 866 1Sea cucumbers fast track organ regrowth by healing their wounds 866 2Manor Care Shareholders Vote to Approve 246 3 Billion Carlyle Buyout 3989 1Manor Care Shareholders Vote to Approve 246 3 Billion Carlyle Buyout 3989 2Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 1Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 2Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 3Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 4Boston Scientific Announces New Initiatives to Increase Shareholder Value 3987 5DNC 3A With Orr Appointment Bush Republicans Put Partisan Ideology Ahead of Good Policy 3985 1
...INCOLNSHIRE, Ill.--(BUSINESS WIRE)--Jul 11, 2007 -...announced new positive,results demonstrating that ...cine adjuvant, BioVant(TM), may serve as an,effect... sparing,vaccine against H5N1 avian flu, widely kn...tudy using a hemagglutination,inhibition assay (HA...
...LEVERKUSEN, Germany - Biofrontera AG (DSE: B8F) an...esults in the dose finding part,of its phase IIb/I...LA, a gel that combines the active substance 5-ami...0, was strongly and significantly,superior to plac...ALA is used in photodynamic therapy, which elimina...
Other Medicine Technology:BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 2BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 3BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 4Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: